See also this year's filing and all EDGAR filings for this company.
PDF Report 0001541157_2026_Akari_Therapeutics_Plc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001541157, Akari Therapeutics Plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,462,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,430,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 34,000,000 |
| 4 | LiabilitiesCurrent | 12,351,000 |
| 5 | LiabilitiesNoncurrent | 31,000 |
| 6 | remainder_Liabilities | 7,182,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,280,000 |
| 9 | ResearchAndDevelopmentExpense | 2,815,000 |
| 10 | remainder_Expenses | 4,177,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,026,000 |
| 13 | remainder_ComprehensiveNetIncome | -44,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 47,892,000 |
| 1 | Liabilities | 19,564,000 |
| 2 | Expenses | 16,272,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 28,328,000 |
| 5 | NetIncome | -17,298,000 |
| 6 | ComprehensiveNetIncome | -17,320,000 |
| 7 | BaseVar | 42,399,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.32 |
| 9 | EconomicCapitalRatio | 2.55 |
Edgar->Model Mapping
Feature Distribution
Change over Time
